Heather Boerner

Freelance Science Writer/Editor

AS SEEN ON

thebodypro.com

Get in Touch

Geo Focus

Coverage Attributes:

Beta

Cites Data: 50 %

Legal Policy Regulation: 25 %

Government Announcement: 25 %

Themes Covered:

Not enough data

Most Recent Topics:

HIV
Prevention
Vaginal Bacteria
Gender-Affirming Care
Transgender Kids

Pitching Insights

Heather's coverage heavily revolves around scientific and healthcare topics, particularly focused on HIV prevention, gender-affirming care for transgender kids, and vaginal bacteria's impact on HIV. Her articles often cite data and cover legal policy regulations as well as government announcements.

If you are looking to pitch to Heather Boerner, consider providing data-backed insights or expert commentary related to the scientific aspects of healthcare, especially those concerning HIV prevention strategies or gender-affirming care for transgender children. Additionally, pitches that touch upon legal policies and government initiatives in these areas may also attract her interest.

Given that there is no specific geographic focus mentioned for Heather Boerner’s work, it would be beneficial to present information with a global perspective when reaching out.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Articles

Scientific American

What the Science on Gender-Affirming Care for Transgender Kids Really Shows

Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.

PBS

Why a promising new approach to HIV prevention could lose funding

NIH officials have announced that after 2020, they don’t plan to fund topical HIV prevention products like douches or gels, unless they can protect the whole body, or unless early studies have shown they can substantially reduce HIV risk.

PBS

Uncovering the female body’s secret protection against HIV

New research highlights the vagina as a powerful HIV prevention tool.

PBS

How vaginal bacteria could be stoking HIV cases and blocking prevention

At the International AIDS Conference in Durban today, researchers at the Center for the AIDS Programme of Research in South Africa (CAPRISA) will unveil startling new evidence of a bacterial culprit that could be responsible for as many as two out of every five new cases of HIV among women. They’ll also reveal how another bacteria blocks the effectiveness of pills to treat HIV and AIDS.

Making Clinical Trials of PrEP More Inclusive of Women, No Matter Their Pregnancy Status

Three new trials of HIV prevention drugs seek to answer directly a question that researchers inside and outside the field of HIV have explicitly avoided for years: How do drugs work -- and are they safe -- in pregnant and breastfeeding women?...

PrEP as Integrated Care: Removing Barriers, Addressing Real Needs

When it comes to getting PrEP to more than just white, cisgender gay men, real talk is essential, according to Darrianne Martin, HIV prevention manager with AltaMed, an L.A.-based health center that serves primarily a Latinx population....